May 19, 2017

New in BMC Medicine - April 2017

BMC Medicine
Impact Factor: 8.005*

Dear Dr Wirawan,

We are pleased to share with you our April content update, featuring journal news, top articles and our most recent table of contents.

Table of Contents


Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis


eHealth in the future of medications management: personalisation, monitoring and adherence

The new field of 'precision psychiatry'


Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women

Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

Incentivised chronic disease management and the inverse equity hypothesis: findings from a longitudinal analysis of Scottish primary care practice-level data

S100β as a serum marker in endocrine resistant breast cancer

Antidepressant use and cognitive decline in community-dwelling elderly people – The Three-City Cohort

Accuracy of low-density lipoprotein cholesterol estimation at very low levels

Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial

Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

Effects of unconditional cash transfers on the outcome of treatment for severe acute malnutrition (SAM): a cluster-randomised trial in the Democratic Republic of the Congo

The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England

Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children


Emerging concepts in liquid biopsies

Benefits of publishing with us

2016 median turnover times: initial decision three days; first decision after peer review 40 days
Portable peer review
Broad medical readership

Follow @BMCMedicine on Twitter

Kind regards,

The BMC Medicine team

*The Impact Factor (IF) is just one measure used for evaluating the impact of research. For further information on the IF and alternative metrics used to measure the impact of research, please click here.